Morgan Stanley’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.6M Buy
683,789
+112,812
+20% +$15.8M ﹤0.01% 1627
2025
Q4
$93.6M Buy
570,977
+86,002
+18% +$13.5M 0.01% 1516
2025
Q3
$64.8M Sell
484,975
-44,144
-8% -$5.36M ﹤0.01% 1794
2025
Q2
$65.8M Sell
529,119
-55,232
-9% -$7.03M ﹤0.01% 1660
2025
Q1
$74.4M Buy
584,351
+59,243
+11% +$9.12M 0.01% 1474
2024
Q4
$75.6M Sell
525,108
-71,389
-12% -$10.2M 0.01% 1468
2024
Q3
$88.8M Buy
596,497
+20,880
+4% +$2.99M 0.01% 1338
2024
Q2
$72.6M Buy
575,617
+31,061
+6% +$4.87M 0.01% 1407
2024
Q1
$100M Sell
544,556
-537,508
-50% -$102M 0.01% 1193
2023
Q4
$195M Buy
1,082,064
+596,664
+123% +$92.9M 0.01% 1169
2023
Q3
$77.2M Buy
485,400
+27,747
+6% +$4.54M 0.01% 1233
2023
Q2
$64.7M Buy
457,653
+91,506
+25% +$14.7M 0.01% 1370
2023
Q1
$61.6M Sell
366,147
-49,171
-12% -$8.77M 0.01% 1363
2022
Q4
$70.3M Buy
415,318
+151,754
+58% +$27.5M 0.01% 1249
2022
Q3
$49.3M Buy
263,564
+39,307
+18% +$8.29M 0.01% 1326
2022
Q2
$36.4M Buy
224,257
+80,889
+56% +$12.8M ﹤0.01% 1652
2022
Q1
$27M Buy
143,368
+17,711
+14% +$3.36M ﹤0.01% 1807
2021
Q4
$33.3M Buy
125,657
+36,511
+41% +$9.84M ﹤0.01% 1657
2021
Q3
$25.8M Sell
89,146
-33,738
-27% -$8.66M ﹤0.01% 1823
2021
Q2
$24.5M Buy
122,884
+7,063
+6% +$1.37M ﹤0.01% 1936
2021
Q1
$22.5M Buy
115,821
+6,170
+6% +$1.27M ﹤0.01% 1801
2020
Q4
$21M Buy
109,651
+51,663
+89% +$9.4M ﹤0.01% 1772
2020
Q3
$8.56M Buy
57,988
+18,130
+45% +$2.59M ﹤0.01% 2166
2020
Q2
$4.93M Buy
39,858
+6,340
+19% +$746K ﹤0.01% 2688
2020
Q1
$3.24M Sell
33,518
-88,170
-72% -$8.51M ﹤0.01% 2888
2019
Q4
$11.3M Sell
121,688
-128,527
-51% -$10.8M ﹤0.01% 2302
2019
Q3
$19.2M Buy
250,215
+44,419
+22% +$3.89M 0.01% 1522
2019
Q2
$17.7M Buy
205,796
+55,814
+37% +$3.8M ﹤0.01% 1582
2019
Q1
$8.86M Sell
149,982
-196,540
-57% -$11.3M ﹤0.01% 2150
2018
Q4
$18.3M Buy
346,522
+92,789
+37% +$5.44M 0.01% 1536
2018
Q3
$14.1M Buy
253,733
+83,226
+49% +$4.29M ﹤0.01% 2045
2018
Q2
$8.02M Buy
170,507
+79,236
+87% +$3.26M ﹤0.01% 2623
2018
Q1
$3.3M Sell
91,271
-18,805
-17% -$661K ﹤0.01% 3497
2017
Q4
$3.99M Buy
110,076
+39,121
+55% +$1.42M ﹤0.01% 3335
2017
Q3
$2.72M Buy
70,955
+24,857
+54% +$1.04M ﹤0.01% 3577
2017
Q2
$1.91M Sell
46,098
-19,801
-30% -$752K ﹤0.01% 3841
2017
Q1
$2.32M Sell
65,899
-39,421
-37% -$1.25M ﹤0.01% 3680
2016
Q4
$3.25M Buy
105,320
+81,461
+341% +$2.52M ﹤0.01% 3434
2016
Q3
$720K Sell
23,859
-90,107
-79% -$2.72M ﹤0.01% 4275
2016
Q2
$3.12M Sell
113,966
-95,343
-46% -$2.44M ﹤0.01% 3043
2016
Q1
$5.61M Buy
209,309
+87,425
+72% +$2.14M ﹤0.01% 2415
2015
Q4
$3.45M Sell
121,884
-40,190
-25% -$1.16M ﹤0.01% 3022
2015
Q3
$4.51M Buy
162,074
+102,485
+172% +$3.7M ﹤0.01% 2750
2015
Q2
$2.46M Buy
59,589
+36,511
+158% +$1.34M ﹤0.01% 3431
2015
Q1
$701K Buy
23,078
+5,554
+32% +$144K ﹤0.01% 4400
2014
Q4
$347K Sell
17,524
-66,018
-79% -$1.48M ﹤0.01% 4925
2014
Q3
$1.66M Sell
83,542
-25,699
-24% -$541K ﹤0.01% 3586
2014
Q2
$2.49M Buy
109,241
+18,666
+21% +$332K ﹤0.01% 3306
2014
Q1
$1.16M Sell
90,575
-179
-0.2% -$2.57K ﹤0.01% 3862
2013
Q4
$1.24M Buy
90,754
+30,439
+50% +$363K ﹤0.01% 3753
2013
Q3
$669K Sell
60,315
-46,869
-44% -$466K ﹤0.01% 4125
2013
Q2
$883K Buy
+107,184
New +$900K ﹤0.01% 3824

Other funds holding RGEN

Morgan Stanley's RGEN Position: Q1 2026 in Review

Morgan Stanley increased its Repligen (RGEN) stake by 20% in Q1 2026, buying an estimated $15.8M and bringing the position to 683,789 shares worth $80.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1627.

Morgan Stanley first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $195M in Q4 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Morgan Stanley held 683,789 shares of Repligen worth $80.6M as of Q1 2026.
  • Morgan Stanley bought 112,812 Repligen shares in Q1 2026, an estimated $15.8M.
  • Repligen made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #1627 holding.
  • Morgan Stanley first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Repligen position peaked at $195M in Q4 2023.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.